December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

51.99 -0.97 (-1.82%)
Streaming Delayed Price Updated: 1:07 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
45 46 Next >
News headline image
Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07 ↗
Benzinga 
Via Benzinga
News headline image
Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac ↗
 
Via Benzinga
News headline image
These 3 Stocks Escaped Tuesday's Market Downdraft ↗
Even a dour outlook for the broader stock market couldn't outweigh good news for these companies. 
Via The Motley Fool
News headline image
Why GSK Plc And Sanofi SA Stock Are Shooting Higher ↗
Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit. 
Via Benzinga
News headline image
GSK's Debt Overview ↗
Over the past three months, shares of GSK Inc. (NYSE:GSK) moved higher by 19.05%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
News headline image
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients ↗
 
Via Benzinga
News headline image
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations ↗
 
Via Benzinga
News headline image
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
From Singapore Economic Development Board (EDB)A*STAR
Via ACN Newswire
News headline image
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment 
Via MarketBeat
Topics Intellectual Property
News headline image
European Official Says COVID-19 Booster Uptake Disappointing In The Region ↗
Marco Cavaleri, the European Medicines Agency's (EMA) head of health threats and vaccines strategy, said the recent uptake of COVID-19 vaccine booster doses in the region has been "rather... 
Via Benzinga
News headline image
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains ↗
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection. 
Via Benzinga
News headline image
Why Vir Biotechnology Jumped Nearly 19% Today ↗
A COVID-19 partnership with a major drugmaker is producing more fruit than expected. 
Via The Motley Fool
News headline image
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early ↗
 
Via Benzinga
News headline image
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US ↗
 
Via Benzinga
News headline image
Dividend Income Update October 2022 ↗
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
News headline image
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says ↗
 
Via Benzinga
News headline image
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting ↗
 
Via Benzinga
News headline image
Peering Into GSK's Recent Short Interest ↗
GSK's (NYSE:GSK) short percent of float has fallen 11.39% since its last report. The company recently reported that it has 13.36 million shares sold short, which is 0.7% of all regular shares that are... 
Via Benzinga
News headline image
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat ↗
Shingrix and specialty medicines helped drive GSK's third-quarter growth. 
Via Investor's Business Daily
News headline image
GSK Lifts Annual Outlook After Robust Vaccines, Specialty Medicine Sales In Q3 ↗
 
Via Benzinga
News headline image
GSK's Debt Overview ↗
Over the past three months, shares of GSK Inc. (NYSE:GSK) decreased by 16.74%. Before having a look at the importance of debt, let's look at how much debt GSK has. 
Via Benzinga
News headline image
Daily Stock Analysis: GSK plc ↗
By my dogcatcher ideal, this is a likely time to buy GSK plc shares based on their dividends for the coming year 2022-23. 
Via Talk Markets
News headline image
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗
 
Via Benzinga
News headline image
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles ↗
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen. 
Via Investor's Business Daily
News headline image
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care ↗
 
Via Benzinga
News headline image
Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex ↗
Deals, financings, trials and approvals in Chinese biotech/biopharma this week. 
Via Talk Markets
News headline image
Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth ↗
Sales of Vir Biotechnology and GSK's Covid antibody almost tripled sales estimates. 
Via Investor's Business Daily
News headline image
Moderna's Earnings Collapsed. Time to Sell? ↗
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills. 
Via The Motley Fool
News headline image
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02 ↗
Reuters 
Via Benzinga
News headline image
Recap: GSK Q3 Earnings ↗
GSK (NYSE:GSK) reported its Q3 earnings results on Wednesday, November 2, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings GSK beat estimated earnings by 15.63%,... 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.